Related Experiment Video
Updated: Jul 7, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Role of sulfonamide group in matrix metalloproteinase inhibitors
Xian-Chao Cheng1, Qiang Wang, Hao Fang
1Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China. chengxianchao2000@yahoo.com.cn
Abstract:
Sulfonamide hydroxamates were designed and synthesized as efficient matrix metalloproteinase (MMP) inhibitors since the discovery of CGS 27023A in 1994. The sulfonamide group was incorporated in the inhibitor to improve the enzyme-inhibitor binding, not only by forming hydrogen bonds to the enzyme but also by properly directing the hydrophobic substituent to the S1' pocket and enabling it to plunge in deeply. Some researchers even presumed that the sulfonamide group, together with the zinc binding group (ZBG), coordinated the zinc ion within the MMP active site. This review will illustrate the role of the sulfonamide group in MMP inhibitors.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Drug Metabolism: Phase II Reactions
Preparation and Reactions of Sulfides
Antihypertensive Drugs: Thiazide-Class Diuretics
Antiprotozoal Agents
